Chronic spontaneous urticaria (CSU) is responsible for 80% of all cases of chronic hives, but 90% of people never know what ...

Hives or urticaria are itchy bumps that appear on the skin. They can be big or small, vary in shape, and can appear anywhere ...

KIT antibody has shown promise in a Phase 1b/2a test in people with certain irritable skin conditions, sending its shares ...

Jasper Therapeutics has reported complete responses in 10 of the 12 chronic hives patients who received the high dose of its ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Harris has seasonal allergies and urticaria, which are chronic hives as a result of allergies. She typically manages her ...

REDWOOD CITY, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company ...

Shares of Jasper Therapeutics climbed after the company reported positive data from a trial of briquilimab, its novel antibody therapy for the treatment of mast cell-driven diseases. The stock was up ...

Harris has seasonal allergies and urticaria, which are chronic hives as a result of allergies. She typically manages her allergies with over-the-counter allergy medication and for the past three ...

Briquilimab was well tolerated in the study. No SAEs or AEs grade 3 were reported. Furthermore, there were no reported AEs related to hair or skin color changes, hypersensitivity, or anemia. Mild ...